Treatment protocols of bisphosphonate-related osteonecrosis of the jaws.
Kyrgidis
Athanassios
A
Koloutsos
Georgios
G
Vahtsevanos
Konstantinos
K
D050071:Bone Density Conservation Agents / Q000008:administration & dosage / Q000009:adverse effects*; D003131:Combined Modality Therapy; D003646:Debridement / Q000379:methods; D004164:Diphosphonates / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007571:Jaw Diseases / Q000139:chemically induced / Q000628:therapy*; D008297:Male; D010020:Osteonecrosis / Q000139:chemically induced / Q000628:therapy*; D012720:Severity of Illness Index; D016896:Treatment Outcome
D050071:Bone Density Conservation Agents; D004164:Diphosphonates